Evolocumab Clinical Trials
3 recruitingDrug
Phase 21Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 2
YN001-004 in Patients With Coronary Atherosclerosis in Australia
Coronary Artery DiseaseCoronary Atherosclerotic Disease
Beijing Inno Medicine Co., Ltd.24 enrolled7 locationsNCT06700720
Recruiting
Phase 4
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
Stable Coronary Disease
Brigham and Women's Hospital50 enrolled1 locationNCT05152888
Recruiting
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals2,382 enrolled20 locationsNCT06858332